• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[酶制剂溶壁酶对动物纤维蛋白溶解的作用]

[Effect of the enzyme preparation longolytin on fibrinolysis in animals].

作者信息

Serebriakova T N, Andreenko G V, Tsymanovich S G, Maksimova R A, Sharkova T S

出版信息

Nauchnye Doki Vyss Shkoly Biol Nauki. 1985(2):66-71.

PMID:3157406
Abstract

It has been established that fibrinolytically active enzyme longolytine isolated from the culture fluid of the saprophyte fungus Arthrobotrys longa at intravenous injection favours the prolonged increase of the plasma fibrinolytic properties as well as activation of endogenic plasminogen. Maximum values of fibrinolytic activity have been marked in 5 and 30 min after enzyme intravenous injection. The plasminogen activity is high in 120 min. The fibrinolysis indexes--fibrinolytic activity of the euglobulin fraction and amount of plasminogen activator--in 3,5 and 5 times higher than in vitro at intravenous injection. The activation of coagulation system does not occur.

摘要

已经确定,从腐生真菌长柄节丛孢菌培养液中分离出的具有纤溶活性的酶longolytine静脉注射后,有利于血浆纤溶特性的长期增加以及内源性纤溶酶原的激活。酶静脉注射后5分钟和30分钟时纤溶活性达到最大值。120分钟时纤溶酶原活性较高。纤溶指标——优球蛋白组分的纤溶活性和纤溶酶原激活剂的量——在静脉注射时比体外高3、5和5倍。凝血系统未被激活。

相似文献

1
[Effect of the enzyme preparation longolytin on fibrinolysis in animals].[酶制剂溶壁酶对动物纤维蛋白溶解的作用]
Nauchnye Doki Vyss Shkoly Biol Nauki. 1985(2):66-71.
2
[Fibrinolytic system of animals repeatedly and chronically administered plasminogen tissue activator].[反复长期给予纤溶酶原组织激活剂的动物的纤溶系统]
Vopr Med Khim. 1981 Nov-Dec;27(6):823-8.
3
[Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].[单次给予组织型纤溶酶原激活剂对大鼠血液纤溶系统状态的影响]
Vopr Med Khim. 1981 Jan-Feb;27(1):77-80.
4
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较
Thromb Haemost. 1981 Jun 30;45(3):225-9.
5
[Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].[生理激活剂和真菌源酶作用诱导动物纤维蛋白溶解系统成分的变化]
Nauchnye Doki Vyss Shkoly Biol Nauki. 1983(3):51-4.
6
[Role of the initial level of plasminogen activator in changes in fibrinolysis].[纤溶酶原激活剂初始水平在纤溶变化中的作用]
Fiziol Zh SSSR Im I M Sechenova. 1983 Mar;69(3):380-5.
7
Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.患有急性胃肠道疾病马匹的血管内和腹膜内凝血与纤溶
J Am Vet Med Assoc. 1995 Aug 15;207(4):465-70.
8
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.口服避孕药使用期间纤溶活性增加被纤溶增强的不依赖于因子XI的下调所抵消:两种低剂量口服避孕药的随机交叉研究。
Thromb Haemost. 2000 Jul;84(1):9-14.
9
Peripheral and gastric fibrinolysis in patients with gastric carcinoma.胃癌患者的外周及胃纤维蛋白溶解
Z Exp Chir. 1975;8(5):309-12.
10
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.高血浆纤维蛋白原水平与弥散性血管内凝血患者的不良临床结局相关。
Am J Hematol. 2003 Jan;72(1):1-7. doi: 10.1002/ajh.10249.